Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 50 Women only

Dose of bupivacaine needed for pain relief in labor with lidocaine test dose

Official title: ED90 of Epidural Bupivacaine for the Initiation of Labor Analgesia: A Randomized Biased Coin Sequential Allocation Trial With a Lidocaine Test Dose

Run by Brigham and Women's Hospital · NCT05543694 · Data updated 2026-11-12

This trial tests the amount of bupivacaine needed to give initial comfortable pain relief for laboring women who receive a lidocaine test dose before an epidural.

More Analgesia trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 50 Years
SexWomen only
Enrollment120 (estimated)
SponsorBrigham and Women's Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedOctober 1, 2022
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedJuly 13, 2026
Trial IDNCT05543694 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant women at term (37–42 weeks) undergoing labor with planned epidural analgesia, without major comorbidities and who request analgesia, with pain score of 5 or higher at the time of epidural request.

Probably not a fit

Women not receiving an epidural or those with contraindications to neuraxial analgesia may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional Phase 4 study uses a biased-coin up-down method to estimate the ED90 dose of bupivacaine for epidural analgesia during labor, comparing dural puncture epidural (DPE) and epidural plus local infiltration (EPL) techniques in women undergoing labor with induction or augmentation. Participants receive a lidocaine test dose per standard practice before epidural analgesia. Primary outcome is the dose of bupivacaine achieving initial comfort in 90% of patients with adequate precision. The study is conducted at Brigham and Women's Hospital, with no listed collaborators. Safety monitoring and standard obstetric analgesia protocols will be followed.

Why it matters

Potential benefit: If successful, the study could define precise bupivacaine dosing guidelines to reliably achieve early pain relief during labor.

How similar studies have gone: Previous work in neuraxial analgesia has used dose-tinding methods; this study applies a specific up-down allocation to estimate ED90 for this context, with mixed technique comparison.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Parturient with no major co-morbidities
* Singleton, vertex gestation at term (37-42 weeks)
* Less than or equal to 5 cm dilation
* Desire to receive epidural labor analgesia
* Numerical Rating Scale greater or equal to 5 (NRS 0-10, where 0 = no pain, and 10 = worst pain imaginable), at time of epidural labor analgesia request.

Exclusion Criteria:

* Current or historical evidence of clinically significant disease or condition, including diseases of pregnancy (i.e preeclampsia, gestational diabetes)
* Any contraindication to the administration of an epidural technique
* History of hypersensitivity or idiosyncratic reaction to an amide local anesthetic agent
* Current or historical evidence of a disease which may result in the risk of a cesarean delivery (i.e. history of uterine rupture). NB: Exception-trial of labor after cesarean delivery (TOLAC) will be eligible.
* Evidence of anticipated fetal anomalies

Where it's running

  • Brigham and Women's Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.